Sumitomo Mitsui Trust Investment
Signal active
Investment Firm
Overview
Sumitomo Mitsui Trust provides Japanese equity products for corporate and governmental pension funds. SMTB also provides products investing in Asian equities. The capability was developed through its experience in Japanese equity, although it maintains an investment team in Hong Kong.
Highlights
Founded
2000
Industry
Financial Services
Employees
11-50
Investment
27
Lead Investment
3
Exits
6
Stages
Late Stage Venture, Early Stage Venture, Private Equity
Investor Type
Venture Capital
Location
Asia
Contact Information
Social
Profile Resume
Sumitomo Mitsui Trust Investment, established in 2000 and headquartered in Asia., specializes in Late Stage Venture, Early Stage Venture, Private Equity investments across Software, Financial Services, Finance, Banking, Accounting, Venture Capital, Impact Investing, Internet, E-Commerce, Mobile. The organization boasts a portfolio of 27 investments, with an average round size of $33.4M and 6 successful exits. Their recent investments include Freee, Headline, DCM Ventures, Mercari, WiL (World Innovation Lab). The highest investment round they participated in was $93.6B. Among their most notable exits are Freee and Headline. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
Sumitomo Mitsui Trust Investment has made 27 investments. Their most recent investment was on Jul 05, 2023, when CADDi raised $81.7M.
investments
27
Diversity investments
0
Lead investments
3
Number of exits
6
Investments
27
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Mar 28, 2022 | Aculys Pharma | Pharmaceutical | 22.7M |
| May 25, 2023 | Heartseed | Biotechnology | 14.3M |
| Jun 14, 2023 | FLUX | Advertising | 31.4M |
| Jul 05, 2023 | CADDi | Information Services | 81.7M |
Exits
6
Funding Timeline
Funding rounds
27
Investors
0
Funds
3
Funding Rounds
27
Sumitomo Mitsui Trust Investment has raised 27 rounds. Their latest funding was raised on Jul 05, 2023 from a Series C - CADDi round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Mar 28, 2022 | Series B - Aculys Pharma | - | 22.7M | - |
| May 25, 2023 | Series D - Heartseed | - | 14.3M | - |
| Jun 14, 2023 | Series B - FLUX | - | 31.4M | - |
| Jul 05, 2023 | Series C - CADDi | - | 81.7M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.